Macromolecular drugs are typically injected, but oral dosage forms are being developed to improve the treatment of gastrointestinal conditions such as inflammatory bowel disease.
Claus-Michael Lehr
Advertisement
Claus-Michael Lehr is head of the drug delivery department at the Helmholtz-Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany.
Articles by Claus-Michael Lehr
Advertisement
Latest Updated Articles
Oral Delivery of Macromolecular DrugsPublished: July 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Sustainability and Stability in Excipients
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
5
